Find your next paid study

Indiana UniversityNCT02432092

Actual pay is set by the research site.

Observational

Pilot Study of a Mixed-Reality Visual Attention Task for Neglect Diagnosis and Rehabilitation

Neglect, a common and disabling neurological deficit post-CNS injury, profoundly hinders recovery and escalates healthcare costs. Current diagnostic tools are …

Neglect, SensoryNeglect, HemispatialNeglect, Hemisensory

~$10 – $1,125

Actual pay is set by the research site.

Markey OlsonNCT07227844

Locally Advanced Pancreatic AdenocarcinomaLocally Advanced Pancreas CancerLocally Advanced Pancreatic Ductal Adenocarcinoma

A Phase 1/2a, Open Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of XER-001 (Amifostibe for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment of Locally-Advanced Pancreatic Adenocarcinoma

The purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.

Xerient PharmaNCT07157033

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

Evaluation of Computed Tomography X-ray-Pulsatility Index (CT-XPI)

The goal of this clinical trial is to learn if a new computed tomography (CT) lung perfusion imaging method is as effective as standard of care (SOC) CT imagin…

CT ScanComputed Tomography

University of Wisconsin, MadisonNCT07192133

~$75 – $2,000

Actual pay is set by the research site.

The Impact of COVID-19 on Maternal and Neonatal Outcomes

The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially it…

COVID-19Pregnancy; Infection

Pay not disclosed — ask the coordinator

Johns Hopkins UniversityNCT05197621

Observational

The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI

To evaluate the usefulness of an upper extremity assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cor…

SCI - Spinal Cord InjuryUpper Extremity DysfunctionUpper Extremity Problem

Kessler FoundationNCT06349434

Actual pay is set by the research site.

Gastric CancerGastro-esophageal Junction CancerPancreatic Ductal Adenocarcinoma+1 more

A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5863, a T Cell-engaging Bispecific Antibody That Targets Claudin 18.2 (CLDN18.2) and CD3 in Adult Participants With Advanced or Metastatic Solid Tumors

This research is designed to determine if experimental treatment with AZD5863, a T cell-engaging bispecific antibody that targets Claudin 18.2 (CLDN18.2) and C…

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT06005493

Phase 3

A Randomized, Open-label, Phase 3 Trial of Petosemtamab + FOLFIRI/mFOLFOX6 Versus Cetuximab or Bevacizumab + FOLFIRI/mFOLFOX6 as Second-line Treatment in Participants With RAS and BRAF Wild-type, Recurrent, Unresectable or Metastatic Colorectal Cancer

The purpose of this trial is to evaluate how well petosemtamab in combination with chemotherapy works against colorectal cancer that has recurred after previou…

Colorectal Cancer

Lower Urinary Tract SymptomsBPH

~$50 – $2,250

Actual pay is set by the research site.

GenmabNCT07775287

Ultrasound Imaging for the Assessment of Lower Urinary Tract Symptoms

The purpose of this research is to develop an ultrasound (US) based urodynamics (UDS) evaluation of voiding based on successful magnetic resonance imaging (MRI…

University of Wisconsin, MadisonNCT06323109

Actual pay is set by the research site.

Cervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more

A Phase 1/2 Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab, doceta…

Bristol-Myers SquibbNCT04895709

~$150 – $4,500

Actual pay is set by the research site.

Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more

A Phase 1a/1b, Multicenter, Open-label, Dose Escalation/Expansion, Multiple-dose Study to Evaluate the Safety and Activity of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients with locally …

Chronic Obstructive Pulmonary DisorderChronic Obstructive Lung DiseaseEmphysema+1 more

~$150 – $4,500

Actual pay is set by the research site.

Dren Bio

COPD Patient-Powered Research Network

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk …